CRSP Overview
Upcoming Projects (CRSP)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CRSP)
-
An updated look at Vertex & CRISPR's exa-cel in patients with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT)
Tickers: VRTX, CRSP
Executed On: Sep 01, 2023 at 11:30 AM EDT -
A Second View: Discussing the potential Vertex & CRISPR's exa-cel in patients with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT)
Tickers: VRTX, CRSP
Executed On: Apr 26, 2023 at 10:30 AM EDT -
Reviewing EDIT-301 as an experimental cell therapy medicine for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT)
Tickers: EDIT, VRTX, BLUE, CRSP
Executed On: Mar 03, 2023 at 10:00 AM EST -
Discussing the potential Vertex & CRISPR's exa-cel in patients with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT)
Tickers: VRTX, CRSP
Executed On: Jan 26, 2023 at 12:00 PM EST
Expired Projects (CRSP)
Upcoming & Overdue Catalysts (CRSP)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CRSP)
-
NTLA in vivo Hepatitis B Virus (HBV) program by Intellia, based on CRISPR/Cas9 genetic editing system, set for HBV animal trials in 2017
Tickers: NTLA, BAYRY, CRSP
Occurred on: May 01, 2018
Strategic Initiatives (CRSP)
-
Don’t see a strategic initiative related to the company you care about? Create your own!